RecruitingNCT03826264

Transpacific TAVR Registry

a Multinational Multicenter Prospective Transpacific TAVR Registry


Sponsor

Duk-Woo Park, MD

Enrollment

10,000 participants

Start Date

Jun 15, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

The Transpacific TAVR Registry is an observational study collecting data on patients undergoing Transcatheter Aortic Valve Replacement (TAVR) — a minimally invasive procedure to replace a diseased aortic valve without open-heart surgery. The registry tracks outcomes across participating sites in the Asia-Pacific region to improve understanding of TAVR outcomes in this population. You may be eligible if: - You are 19 years old or older - You are scheduled to undergo TAVR - You have provided informed consent You may NOT be eligible if: - There are no additional formal exclusion criteria beyond not meeting the inclusion criteria Talk to your cardiologist about whether your upcoming TAVR procedure is being performed at a participating registry site.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETAVR

transcatheter aortic valve replacement (TAVR)


Locations(7)

Stanford University

Stanford, California, United States

Northwestern Memorial Hospital

Chicago, Illinois, United States

Second Affiliated Hospital of Zhejiang University

Hangzhou, China

Bucheon Sejong Hospital

Bucheon-si, South Korea

Chungnam National University Hospital

Daejeon, South Korea

Asan Medical Center

Seoul, South Korea

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03826264


Related Trials